LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
467
via gurufocus.comBusiness & Companies

Silence Therapeutics agrees to Merck KGaA takeover at 130% premium

FROM THE WIRE · GURUFOCUS.COM

The U.S.-listed biotechnology company Silence Therapeutics (SLN, Financials) consented to Merck KGaA's purchase in an all-cash transaction worth roughly $1.3 bi

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA cash offer at a high premium for a U.S.-listed biotech anchors the share price.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Silence Therapeutics consented to Merck KGaA's purchase.
  2. 02The all-cash transaction is worth roughly $1.3 billion.
  3. 03The takeover premium is 130%.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.